Metal is not inert: Role of metal ions released by biocorrosion in aseptic loosening - Current concepts

Journal of Biomedical Materials Research - Part A

Volumn 91, Issue 4, 2009, Pages 1252-1262

  Cadosch, Dieter ^a,b   Chan, Erwin ^a   Gautschi, Oliver P ^a,b   Filgueira, Luis ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b ROYAL PERTH HOSPITAL   (Australia)

Author keywords

Aseptic loosening; Biocorrosion; Immunoreactivity; Metal implants; Metal ions

Indexed keywords

ASEPTIC LOOSENING; BIOCORROSION; BLOOD CIRCULATION; BONE FRACTURE; BONE METABOLISM; DIFFERENT MECHANISMS; HUMAN BODIES; IMMUNE REACTION; IMMUNE SYSTEMS; IMMUNOREACTIVITIES; JOINT REPLACEMENT; METAL ALLOYS; METAL IMPLANTS; PATHOPHYSIOLOGICAL; THERAPEUTIC TOOLS;

BIODEGRADATION; BONE; CARDIOVASCULAR SYSTEM; JOINT PROSTHESES; METAL IONS; TRACE ANALYSIS;

METALS;

METAL ION; NICKEL; TITANIUM; VANADIUM;

ADAPTIVE IMMUNITY; BONE METABOLISM; CELL INFILTRATION; CIRCULATION; CORROSION; DENDRITIC CELL; ECZEMA; ERYTHEMA; HUMAN; HYPERSENSITIVITY REACTION; IMMUNE SYSTEM; IMMUNOGENICITY; IMMUNOREACTIVITY; INNATE IMMUNITY; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MAST CELL; METAL IMPLANTATION; MONOCYTE; OSTEOBLAST; PHYSICAL CHEMISTRY; PROSTHESIS LOOSENING; PRURITUS; REVIEW; URTICARIA;

BONE AND BONES; CORROSION; HUMANS; IMMUNE SYSTEM; IONS; METALS; PROSTHESIS FAILURE;

EID: 70450247146     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32625     Document Type: Review

References (137)

1. Thull R. Scientific aspects of raw materials in medicine. Naturwissenschaften 1994;81:481-488. (Pubitemid 24360148)
2. Carlsson AS, Magnusson B, Moller H. Metal sensitivity in patients with metal-to-plastic total hip arthroplasties. Acta Orthop Scand 1980;51:57-62. (Pubitemid 10173818)
3. Harris WH. Osteolysis and particle disease in hip replacement. A review. Acta Orthop Scand 1994;65:113-123.
4. Kubba R, Taylor JS, Marks KE. Cutaneous complications of orthopedic implants. A two-year prospective study. Arch Dermatol 1981;117:554-560.
5. Mayor MB, Merritt K, Brown SA. Metal allergy and the surgical patient. Am J Surg 1980;139:477-479.
6. Merritt K, Rodrigo JJ. Immune response to synthetic materials. Sensitization of patients receiving orthopaedic implants. Clin Orthop Relat Res 1996;71-79.
7. Thomas P, Bandl WD, Maier S, Summer B, Przybilla B. Hypersensitivity to titanium osteosynthesis with impaired fracture healing, eczema, and T-cell hyperresponsiveness in vitro: Case report and review of the literature. Contact Derm 2006;55:199-202. (Pubitemid 44350942)
8. Thomas P, Thomsen M. Allergy diagnostics in implant intolerance. Orthopade 2008;37:131-135.
9. Disegi JA, Wyss H. Implant materials for fracture fixation: A clinical perspective. Orthopedics 1989;12:75-79. (Pubitemid 19041345)
10. Pohler O, Strauman F. Characteristics of the stainless steel ASIF/AO implants. Waldeburg, Switzerland: Swiss Association for the study of Internal Fixation; 1975.
11. Tengvall P, Lundstrom I. Physico-chemical considerations of titanium as a biomaterial. Clin Mater 1992;9:115-134.
12. Hallab NJ, Anderson S, Stafford T, Glant T, Jacobs JJ. Lymphocyte responses in patients with total hip arthroplasty. J Orthop Res 2005;23:384-391. (Pubitemid 40287865)
13. Jacobs JJ, Hallab NJ, Skipor AK, Urban RM. Metal degradation products: A cause for concern in metal-metal bearings? Clin Orthop Relat Res 2003;139-147.
14. Singh R, Dahotre NB. Corrosion degradation and prevention by surface modification of biometallic materials. J Mater Sci Mater Med 2007;18:725-751. (Pubitemid 46766556)
15. Cadosch D, Chan E, Gautschi OP, Filgueira L. Bio-corrosion of stainless steel by osteoclasts - In vitro evidence. J Orthop Res 2009;27:841-846.
16. Okazaki Y, Gotoh E, Manabe T, Kobayashi K. Comparison of metal concentrations in rat tibia tissues with various metallic implants. Biomaterials 2004;25:5913-5920. (Pubitemid 38747013)
17. Tezer M, Kuzgun U, Hamzaoglu A, Ozturk C, Kabukcuoglu F, Sirvanci M. Intraspinal metalloma resulting in late paraparesis. Arch Orthop Trauma Surg 2005;125:417-421. (Pubitemid 41102417)
18. Dorr LD, Bloebaum R, Emmanual J, Meldrum R. Histologic, biochemical, and ion analysis of tissue and fluids retrieved during total hip arthroplasty. Clin Orthop Relat Res 1990;82-95.
19. Jacobs JJ, Skipor AK, Patterson LM, Hallab NJ, Paprosky WG, Black J, Galante JO. Metal release in patients who have had a primary total hip arthroplasty. A prospective, controlled, longitudinal study. J Bone Joint Surg Am 1998;80:1447-1458. (Pubitemid 28503259)
20. Savarino L, Granchi D, Ciapetti G, Cenni E, Nardi Pantoli A, Rotini R, Veronesi CA, Baldini N, Giunti A. Ion release in patients with metal-on-metal hip bearings in total joint replacement: A comparison with metal-on-polyethylene bearings. J Biomed Mater Res 2002;63:467-474.
21. Urban RM, Jacobs JJ, Tomlinson MJ, Gavrilovic J, Black J, Peoc'h M. Dissemination of wear particles to the liver, spleen, and abdominal lymph nodes of patients with hip or knee replacement. J Bone Joint Surg Am 2000;82:457-476. (Pubitemid 30202794)
22. Al-Saffar N, Revell PA. Pathology of the bone-implant interfaces. J Long Term Eff Med Implants 1999;9:319-347.
23. Bauer TW. Particles and periimplant bone resorption. Clin Orthop Relat Res 2002;138-143.
24. Korkusuz F, Senkoylu A. Hard tissue-implant interactions-1: New concepts on bone and metal interactions. Joint Dis Relat Surg 2003;14:51-57. (Pubitemid 37039390)
25. Voggenreiter G, Leiting S, Brauer H, Leiting P, Majetschak M, Bardenheuer M, Obertacke U. Immuno-inflammatory tissue reaction to stainless-steel and titanium plates used for internal fixation of long bones. Biomaterials 2003;24:247-254. (Pubitemid 35292567)
26. Bi Y, Van De Motter RR, Ragab AA, Goldberg VM, Anderson JM, Greenfield EM. Titanium particles stimulate bone resorption by inducing differentiation of murine osteoclasts. J Bone Joint Surg Am 2001;83:501-508.
27. Matthews JB, Green TR, Stone MH, Wroblewski BM, Fisher J, Ingham E. Comparison of the response of three human monocytic cell lines to challenge with polyethylene particles of known size and dose. J Mater Sci Mater Med 2001;12:249-258. (Pubitemid 32207080)
28. Sommer B, Felix R, Sprecher C, Leunig M, Ganz R, Hofstetter W. Wear particles and surface topographies are modulators of osteoclastogenesis in vitro. J Biomed Mater Res A 2005;72:67-76. (Pubitemid 39628334)
29. Fanti P, Kindy MS, Mohapatra S, Klein J, Colombo G, Malluche HH. Dose-dependent effects of aluminum on osteocalcin synthesis in osteoblast-like ROS 17/2 cells in culture. Am J Physiol 1992;263:E1113-E1118. (Pubitemid 23024454)
30. Thompson GJ, Puleo DA. Effects of sublethal metal ion concentrations on osteogenic cells derived from bone marrow stromal cells. J Appl Biomater 1995;6:249-258.
31. Cadosch D, Chan E, Gautschi OP, Meagher J, Zellweger R, Filgueira L. Titanium IV ions induced human osteoclast differentiation and enhanced bone resorption in vitro. J Biomed Mater Res A 2009;91:29-36.
32. Martin SF. T lymphocyte-mediated immune responses to chemical haptens and metal ions: Implications for allergic and autoimmune disease. Int Arch Allergy Immunol 2004;134:186-198.
33. Hallab NJ, Caicedo M, Finnegan A, Jacobs JJ. Th1 type lymphocyte reactivity to metals in patients with total hip arthroplasty. J Orthop Surg 2008;3:6.
34. Streich NA, Breusch SJ, Schneider U. Serum levels of interleukin 6 (IL-6), granulocyte-macrophage colony-stimulating factor (GM-CSF) and elastase in aseptic prosthetic loosening. Int Orthop 2003;27:267-271. (Pubitemid 37362644)
35. Taki N, Tatro JM, Lowe R, Goldberg VM, Greenfield EM. Comparison of the roles of IL-1, IL-6, and TNFalpha in cell culture and murine models of aseptic loosening. Bone 2007;40:1276-1283.
36. Thomas P. Allergic reactions to implant materials. Orthopade 2003;32:60-64.
37. Steinemann SG. Metal implants and surface reactions. Injury 1996;27:(Suppl 3)SC16-SC22.
38. Angle CR. Organ-specific therapeutic intervention. In: Goyer RA, Klaassen CD, Waalkes MP, editors. Metal Toxicology. New York: Academic Press; 1995. p 71-110.
39. Bundy KJ. Corrosion and other electrochemical aspects of biomaterials. Crit Rev Biomed Eng 1994;22:139-251.
40. Escalas F, Galante J, Rostoker W, Coogan PH. MP35N: A corrosion resistant, high strength alloy for orthopedic surgical impants: Bio-assay results. J Biomed Mater Res 1975;9:303-313.
41. Gawkrodger DJ. Nickel sensitivity and the implantation of orthopaedic prostheses. Contact Derm 1993;28:257-259.
42. Hallab NJ, Jacobs JJ, Skipor A, Black J, Mikecz K, Galante JO. Systemic metal-protein binding associated with total joint replacement arthroplasty. J Biomed Mater Res 2000;49:353-361. (Pubitemid 30030481)
43. Laing PG. Compatibility of biomaterials. Orthop Clin North Am 1973;4:249-273.
44. Lalor PA, Revell PA, Gray AB, Wright S, Railton GT, Freeman MA. Sensitivity to titanium. A cause implant failure? J Bone Joint Surg Br 1991;73:25-28.
45. Liden C, Wahlberg JE, Mariachi HI. Skin. In: Goyer RA, Klaassen CD, Waalkes MP, editors. Metal Toxicology. New York: Academic Press; 1995. p 447-464.
46. Long M, Rack HJ. Titanium alloys in total joint replacement - A materials science perspective. Biomaterials 1998;19:1621-1639. (Pubitemid 28512843)
47. Mears DC. The use of dissimilar metals in surgery. J Biomed Mater Res 1975;9:133-148.
48. Okazaki Y, Rao S, Ito Y, Tateishi T. Corrosion resistance, mechanical properties, corrosion fatigue strength and cytocompatibility of new Ti alloys without Al and V. Biomaterials 1998;19:1197-1215. (Pubitemid 28395142)
49. Parker AW, Drez D, Jacobs JJ. Titanium dermatitis after failure of a metal-backed patellas. Am J Knee Surg 1993;6:129-131.
50. Scales JT. Black staining around titanium alloy prostheses - An orthopaedic enigma. J Bone Joint Surg Br 1991;73:534-536.
51. Okazaki Y, Gotoh E. Comparison of metal release from various metallic biomaterials in vitro. Biomaterials 2005;26:11-21. (Pubitemid 38759469)
52. Leopold SS, Berger RA, Patterson L, Skipor AK, Urban RM, Jacobs JJ. Serum titanium level for diagnosis of a failed, metal-backed patellar component. J Arthroplasty 2000;15:938-943. (Pubitemid 30804867)
53. Jacobs JJ, Skipor AK, Black J, Urban R, Galante JO. Release and excretion of metal in patients who have a total hipreplacement component made of titanium-base alloy. J Bone Joint Surg Am 1991;73:1475-1486.
54. Purdue PE, Koulouvaris P, Potter HG, Nestor BJ, Sculco TP. The cellular and molecular biology of periprosthetic osteolysis. Clin Orthop Relat Res 2007;454:251-261. (Pubitemid 46074927)
55. Yan Y, Neville A, Dowson D. Understanding the role of corrosion in the degradation of metal-on-metal implants. Proc Inst Mech Eng H 2006;220:173-181.
56. Contu F, Elsener B, Böhni H. Electrochemical behavior of CoCrMo alloy in the active state in acidic and alkaline buffered solution. J Electrochem Soc 2003;150:B419-B424.
57. Khan MA, Williams RL, Williams DF. Conjoint corrosion and wear in titanium alloys. Biomaterials 1999;20:765-772.
58. Williams RL, Brown SA, Merritt K. Electrochemical studies on the influence of proteins on the corrosion of implant alloys. Biomaterials 1988;9:181-186. (Pubitemid 18077888)
59. Zhu J, Xu N, Zhang C. Characteristics of copper corrosion in simulated uterine fluid in the presence of protein. Adv Contracept 1999;15:179-190. (Pubitemid 30693483)
60. Cadosch D, Gautschi OP, Al-Mushaiqri MS, Meagher J, Mhawi A, Filgueira L. In vitro evidence of titanium and aluminium bio-corrosion by human osteoclasts. J Mater Sci Mater Med. Forthcoming.
61. Agarwal S. Osteolysis-basic science, incidence and diagnosis. Curr Orthop 2004;18:220-231.
62. Aspenberg P, Van Der Vis H. Migration, particles, and fluid pressure. A discussion of causes of prosthetic loosening. Clin Orthop Relat Res 1998;75-80.
63. Harris WH. The problem is osteolysis. Clin Orthop Relat Res 1995;46-53.
64. Keener JD, Callaghan JJ, Goetz DD, Pederson DR, Sullivan PM, Johnston RC. Twenty-five-year results after Charnley total hip arthroplasty in patients less than fifty years old: A concise follow-up of a previous report. J Bone Joint Surg Am 2003;85:1066-1072. (Pubitemid 36644789)
65. Pandey R, Quinn J, Joyner C, Murray DW, Triffitt JT, Athanasou NA. Arthroplasty implant biomaterial particle associated macrophages differentiate into lacunar bone resorbing cells. Ann Rheum Dis 1996;55:388-395. (Pubitemid 26189183)
66. Quinn J, Joyner C, Triffitt JT, Athanasou NA. Polymethylmethacrylate- induced inflammatory macrophages resorb bone. J Bone Joint Surg Br 1992;74:652-658.
67. Sabokbar A, Fujikawa Y, Neale S, Murray DW, Athanasou NA. Human arthroplasty derived macrophages differentiate into osteoclastic bone resorbing cells. Ann Rheum Dis 1997;56:414-420. (Pubitemid 27345260)
68. Cho DR, Shanbhag AS, Hong CY, Baran GR, Goldring SR. The role of adsorbed endotoxin in particle-induced stimulation of cytokine release. J Orthop Res 2002;20:704-713.
69. Frokjaer J, Deleuran B, Lind M, Overgaard S, Soballe K, Bunger C. Polyethylene particles stimulate monocyte chemotactic and activating factor production in synovial mononuclear cells in vivo. An immunohistochemical study in rabbits. Acta Orthop Scand 1995;66:303-307.
70. Ishiguro N, Kojima T, Ito T, Saga S, Anma H, Kurokouchi K, Iwahori Y, Iwase T, Iwata H. Macrophage activation and migration in interface tissue around loosening total hip arthroplasty components. J Biomed Mater Res 1997;35:399-406. (Pubitemid 27193931)
71. Nakashima Y, Sun DH, Trindade MC, Chun LE, Song Y, Goodman SB, Schurman DJ, Maloney WJ, Smith RL. Induction of macrophage C-C chemokine expression by titanium alloy and bone cement particles. J Bone Joint Surg Br 1999;81:155-162. (Pubitemid 29043430)
72. Cadosch D, Gautschi OP, Chan E, Simmen HP, Filgueira L. Titanium induced production of chemokines CCL17/TARC and CCL22/MDC in human osteoclasts and osteoblasts. J Biomed Mater Res A 2009 Feb 9 [Epub ahead of print (DOI: 10.1002/jbm.a.32390)].
73. Lean JM, Murphy C, Fuller K, Chambers TJ. CCL9/MIP-1gamma and its receptor CCR1 are the major chemokine ligand/receptor species expressed by osteoclasts. J Cell Biochem 2002;87:386-393. (Pubitemid 35231702)
74. Nakamura ES, Koizumi K, Kobayashi M, Saitoh Y, Arita Y, Nakayama T, Sakurai H, Yoshie O, Saiki I. RANKL-induced CCL22/macrophage-derived chemokine produced from osteoclasts potentially promotes the bone metastasis of lung cancer expressing its receptor CCR4. Clin ExpMetastasis 2006;23:9-18. (Pubitemid 44576775)
75. Fujikawa Y, Quinn JM, Sabokbar A, Mcgee JO, Athanasou NA. The human osteoclast precursor circulates in the monocyte fraction. Endocrinology 1996;137:4058-4060. (Pubitemid 26284685)
76. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998;93:165-176. (Pubitemid 28180851)
77. Greenfield EM, Bi Y, Ragab AA, Goldberg VM, Van De Motter RR. The role of osteoclast differentiation in aseptic loosening. J Orthop Res 2002;20:1-8. (Pubitemid 34071414)
78. Kaar SG, Ragab AA, Kaye SJ, Kilic BA, Jinno T, Goldberg VM, Bi Y, Stewart MC, Carter JR, Greenfield EM. Rapid repair of titanium particle-induced osteolysis is dramatically reduced in aged mice. J Orthop Res 2001;19:171-178. (Pubitemid 32331689)
79. Merkel KD, Erdmann JM, Mchugh KP, Abu-Amer Y, Ross FP, Teitelbaum SL. Tumor necrosis factor-alpha mediates orthopedic implant osteolysis. Am J Pathol 1999;154:203-210. (Pubitemid 29031627)
80. Schwarz EM, Benz EB, Lu AP, Goater JJ, Mollano AV, Rosier RN, Puzas JE, Okeefe RJ. Quantitative small-animal surrogate to evaluate drug efficacy in preventing wear debris-induced osteolysis. J Orthop Res 2000;18:849-855.
81. Kadoya Y, Revell PA, Al-Saffar N, Kobayashi A, Scott G, Freeman MA. Bone formation and bone resorption in failed total joint arthroplasties: Histomorphometric analysis with histochemical and immunohistochemical technique. J Orthop Res 1996;14:473-482. (Pubitemid 26199837)
82. Kim KJ, Hijikata H, Itoh T, Kumegawa M. Joint fluid from patients with failed total hip arthroplasty stimulates pit formation by mouse osteoclasts on dentin slices. J Biomed Mater Res 1998;43:234-240. (Pubitemid 28390324)
83. Kovacik MW, Gradisar IA, Haprian JJ, Alexander TS. Osteolytic indicators found in total knee arthroplasty synovial fluid aspirates. Clin Orthop Relat Res 2000;186-194.
84. Jiranek WA, Machado M, Jasty M, Jevsevar D, Wolfe HJ, Goldring SR, Goldberg MJ, Harris WH. Production of cytokines around loosened cemented acetabular components. Analysis with immunohistochemical techniques and in situ hybridization. J Bone Joint Surg Am 1993;75:863-879. (Pubitemid 23206699)
85. Kim KJ, Rubash HE, Wilson SC, D'antonio JA, Mcclain EJ. A histologic and biochemical comparison of the interface tissues in cementless and cemented hip prostheses. Clin Orthop Relat Res 1993;142-152.
86. Stea S, Visentin M, Granchi D, Ciapetti G, Donati ME, Sudanese A, Zanotti C, Toni A. Cytokines and osteolysis around total hip prostheses. Cytokine 2000;12:1575-1579. (Pubitemid 30786284)
87. Lowe R, Nalepka JL, Van De Motter RR, Goldberg VM, Bi Y, Greenfield EM. Stimulation of osteoclast differentiation by wear debris depends on synergistic interactions between IL-1alpha, IL-1beta, IL-6, and TNF-alpha. Trans Orthop Res Soc 2001;26:959.
88. Ragab AA, Nalepka JL, Bi Y, Greenfield EM. Cytokines synergistically induce osteoclast differentiation: Support by immortalized or normal calvarial cells. Am J Physiol Cell Physiol 2002;283:C679-C687. (Pubitemid 34920301)
89. Greenfield EM, Bi Y, Miyauchi A. Regulation of osteoclast activity. Life Sci 1999;65:1087-1102.
90. Suda T, Takahashi N, Martin TJ. Modulation of osteoclast differentiation. Endocr Rev 1992;13:66-80.
91. Jimi E, Nakamura I, Ikebe T, Akiyama S, Takahashi N, Suda T. Activation of NF-kappaB is involved in the survival of osteoclasts promoted by interleukin-1. J Biol Chem 1998;273:8799-8805. (Pubitemid 28176159)
92. Yao J, Cs-Szabo G, Jacobs JJ, Kuettner KE, Glant TT. Suppression of osteoblast function by titanium particles. J Bone Joint Surg Am 1997;79:107-112. (Pubitemid 27057457)
93. Aguila HL, Rowe DW. Skeletal development, bone remodeling, and hematopoiesis. Immunol Rev 2005;208:7-18.
94. Fouque-Aubert A, Chapurlat R. Influence of RANKL inhibition on immune system in the treatment of bone diseases. Joint Bone Spine 2008;75:5-10.
95. Sato K, Suematsu A, Okamoto K, Yamaguchi A, Morishita Y, Kadono Y, Tanaka S, Kodama T, Akira S, Iwakura Y, Cua DJ, Takayanagi H. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med 2006;203:2673-2682. (Pubitemid 44833343)
96. Schmidt-Weber CB, Akdis M, Akdis CA. TH17 cells in the big picture of immunology. J Allergy Clin Immunol 2007;120:247-254.
97. Granchi D, Ciapetti G, Stea S, Savarino L, Filippini F, Sudanese A, Zinghi G, Montanaro L. Cytokine release in mononuclear cells of patients with Co-Cr hip prosthesis. Biomaterials 1999;20:1079-1086. (Pubitemid 29233381)
98. Hallab NJ, Anderson S, Caicedo M, Skipor A, Campbell P, Jacobs JJ. Immune responses correlate with serum-metal in metal-on-metal hip arthroplasty. J Arthroplasty 2004;19:(8 Suppl 3)88-93. (Pubitemid 39575835)
99. Huang W, O'keefe RJ, Schwarz EM. Exposure to receptora-ctivator of NFkappaB ligand renders pre-osteoclasts resistant to IFN-gamma by inducing terminal differentiation. Arthritis Res Ther 2003;5:R49-R59.
100. Ingham E, Fisher J. The role of macrophages in osteolysis of total joint replacement. Biomaterials 2005;26:1271-1286. (Pubitemid 39314501)
101. Ritchlin CT, Haas-Smith SA, Li P, Hicks DG, Schwarz EM. Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis. J Clin Invest 2003;111:821-831. (Pubitemid 37074957)
102. Romas E, Gillespie MT, Martin TJ. Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis. Bone 2002;30:340-346. (Pubitemid 34154863)
103. Moreno JL, Kaczmarek M, Keegan AD, Tondravi M. IL-4 suppresses osteoclast development and mature osteoclast function by a STAT6-dependent mechanism: Irreversible inhibition of the differentiation program activated by RANKL. Blood 2003;102:1078-1086. (Pubitemid 36917809)
104. Takayanagi H, Ogasawara K, Hida S, Chiba T, Murata S, Sato K, Takaoka A, Yokochi T, Oda H, Tanaka K, Nakamura K, Taniguchi T. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. Nature 2000;408:600-605.
105. Sypniewska G, Lis K, Bilinski PJ. Bone turnover markers and cytokines in joint fluid: Analyses in 10 patients with loose hip prosthesis and 39 with coxarthrosis. Acta Orthop Scand 2002;73:518-522. (Pubitemid 35252459)
106. Looney RJ, Schwarz EM, Boyd A, O'keefe RJ. Periprosthetic osteolysis: An immunologist's update. Curr Opin Rheumatol 2006;18:80-87.
107. Rustemeyer T, Von Blomberg BM, Van Hoogstraten IM, Bruynzeel DP, Scheper RJ. Analysis of effector and regulatory immune reactivity to nickel. Clin Exp Allergy 2004;34:1458-1466. (Pubitemid 39233703)
108. Foussereau J, Laugier P. Allergic eczemas from metallic foreign bodies. Trans St Johns Hosp Dermatol Soc 1966;52:220-225.
109. Katou F, Andoh N, Motegi K, Nagura H. Immuno-inflammatory responses in the tissue adjacent to titanium miniplates used in the treatment of mandibular fractures. J Craniomaxillofac Surg 1996;24:155-162. (Pubitemid 26334714)
110. Perry MJ, Mortuza FY, Ponsford FM, Elson CJ, Atkins RM. Analysis of cell types and mediator production from tissues around loosening joint implants. Br J Rheumatol 1995;34:1127-1134.
111. Torgersen S, Moe G, Jonsson R. Immunocompetent cells adjacent to stainless steel and titanium miniplates and screws. Eur J Oral Sci 1995;103:46-54.
112. Holgers KM, Thomsen P, Tjellstrom A, Bjursten LM. Immunohistochemical study of the soft tissue around long-term skin-penetrating titanium implants. Biomaterials 1995;16:611-616.
113. Gristina AG. Implant failure and the immuno-incompetent fibro-inflammatory zone. Clin Orthop Relat Res 1994;106-118.
114. Granchi D, Verri E, Ciapetti G, Stea S, Savarino L, Sudanese A, Mieti M, Rotini R, Dallari D, Zinghi G, Montanaro L. Bone-resorbing cytokines in serum of patients with aseptic loosening of hip prostheses. J Bone Joint Surg Br 1998;80:912-917. (Pubitemid 28457091)
115. Budinger L, Hertl M. Immunologic mechanisms in hypersensitivity reactions to metal ions: An overview. Allergy 2000;55:108-115. (Pubitemid 30106015)
116. Thewes M, Kretschmer R, Gfesser M, Rakoski J, Nerlich M, Borelli S, Ring J. Immunohistochemical characterization of the perivascular infiltrate cells in tissues adjacent to stainless steel implants compared with titanium implants. Arch Orthop Trauma Surg 2001;121:223-226. (Pubitemid 32236996)
117. Kumazawa R, Watari F, Takashi N, Tanimura Y, Uo M, Totsuka Y. Effects of Ti ions and particles on neutrophil function and morphology. Biomaterials 2002;23:3757-3764. (Pubitemid 34626576)
118. Mu Y, Kobayashi T, Sumita M, Yamamoto A, Hanawa T. Metal ion release from titanium with active oxygen species generated by rat macrophages in vitro. J Biomed Mater Res 2000;49:238-243.
119. Cavani A, Nasorri F, Prezzi C, Sebastiani S, Albanesi C, Girolomoni G. Human CD4+ T lymphocytes with remarkable regulatory functions on dendritic cells and nickel-specific Th1 immune responses. J Invest Dermatol 2000;114:295-302. (Pubitemid 30417764)
120. Guo M, Sun H, Mcardle HJ, Gambling L, Sadler PJ. Ti(IV) uptake and release by human serum transferrin and recognition of Ti(IV)-transferrin by cancer cells: Understanding the mechanism of action of the anticancer drug titanocene dichloride. Biochemistry 2000;39:10023-10033. (Pubitemid 30663023)
121. Messori L, Orioli P, Banholzer V, Pais I, Zatta P. Formation of titanium(IV) transferrin by reaction of human serum apotransferrin with titanium complexes. FEBS Lett 1999;442: 157-161. (Pubitemid 29070825)
122. Sun HZ, Li HY, Weir RA, Sadler PJ. The first specific TiIV protein complex: Potential relevance to anticancer activity of titanocenes. Angew Chem 1998;37:1577-1579.
123. Tinoco AD, Eames EV, Valentine AM. Reconsideration of serum Ti(IV) transport: Albumin and transferrin trafficking of Ti(IV) and its complexes. J Am Chem Soc 2008;130:2262-2270.
124. Chen CT, Chen YC. Fe3O4/TiO2 core/shell nanoparticles as affinity probes for the analysis of phosphopeptides using TiO2 surface-assisted laser desorption/ionization mass spectrometry. Anal Chem 2005;77:5912-5919.
125. Ikeguchi Y, Nakamura H. Determination of organic phosphates by column-switching high performance anionexchange chromatography using on-line preconcentration on titania. Anal Sci 1997;13:479-483. (Pubitemid 127479861)
126. Ikeguchi Y, Nakamura H. Selective enrichment of phospholipids by titania. Anal Sci 2000;16:541-543.
127. Kawahara M, Nakamura H, Nakajima T. Group separation of ribonucleosides and deoxyribonucleosides on a new ceramic titania column. Anal Sci 1989;5:763-764.
128. Granchi D, Savarino L, Ciapetti G, Cenni E, Rotini R, Mieti M, Baldini N, Giunti A. Immunological changes in patients with primary osteoarthritis of the hip after total joint replacement. J Bone Joint Surg Br 2003;85:758-764. (Pubitemid 36927048)
129. Granchi D, Cenni E, Trisolino G, Giunti A, Baldini N. Sensitivity to implant materials in patients undergoing total hip replacement. J Biomed Mater Res B Appl Biomater 2006;77:257-264. (Pubitemid 43667448)
130. Swiontkowski MF, Agel J, Schwappach J, Mcnair P, Welch M. Cutaneous metal sensitivity in patients with orthopaedic injuries. J Orthop Trauma 2001;15:86-89. (Pubitemid 33599808)
131. Coleman RF, Herrington J, Scales JT. Concentration of wear products in hair, blood, and urine after total hip replacement. Br Med J 1973;1:527-529.
132. Fisher AA. Patch testing for allergic reactions to metals in orthopedic implants. Cutis 1991;48:183-184.
133. Tan M, Suzuki H. Usefulness of titanium implants for systemic contact dermatitis due to orthopaedic prostheses. Contact Derm 1995;33:202.
134. Hallab NJ, Mikecz K, Jacobs JJ. A triple assay technique for the evaluation of metal-induced, delayed-type hypersensitivity responses in patients with or receiving total joint arthroplasty. J Biomed Mater Res 2000;53:480-489. (Pubitemid 30745179)
135. Hallab N, Merritt K, Jacobs JJ. Metal sensitivity in patients with orthopaedic implants. J Bone Joint Surg Am 2001;83:428-436. (Pubitemid 32221575)
136. Luque I, Leyva L, Jose Torres M, Rosal M, Mayorga C, Segura JM, Blanca M, Juarez C. In vitro T-cell responses to beta-lactam drugs in immediate and nonimmediate allergic reactions. Allergy 2001;56:611-618.
137. Nyfeler B, Pichler WJ. The lymphocyte transformation test for the diagnosis of drug allergy: Sensitivity and specificity. Clin Exp Allergy 1997;27:175-181. (Pubitemid 27085418)